Profil
Sarah Singleton currently works at ImmunityBio, Inc., as Chief Communications Officer from 2020.
Ms. Singleton also formerly worked at NantKwest, Inc., as Head-Global Communications & Investor Relations, Sunverge Energy, Inc., as Senior Vice President-Marketing, and Fleishman-Hillard, Inc., as Senior Vice President & Partner.
Ms. Singleton received her undergraduate degree from E.W.
Scripps School of Journalism.
Aktive Positionen von Sarah Singleton
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNITYBIO, INC. | Public Communications Contact | 01.03.2020 |
Ehemalige bekannte Positionen von Sarah Singleton
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNITYBIO, INC. | Investor Relations Kontakt | 01.01.2019 |
Fleishman-Hillard, Inc.
Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Corporate Officer/Principal | - |
Sunverge Energy, Inc.
Sunverge Energy, Inc. Packaged SoftwareTechnology Services Develops cloud-based energy management platform | Vertrieb & Marketing | - |
Ausbildung von Sarah Singleton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Sunverge Energy, Inc.
Sunverge Energy, Inc. Packaged SoftwareTechnology Services Develops cloud-based energy management platform | Technology Services |
Fleishman-Hillard, Inc.
Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Commercial Services |
E.W. Scripps School of Journalism
E.W. Scripps School of Journalism Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunityBio, Inc.
ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
















